Form 4: Merck & Co. Director, Mary Ellen Coe, Reports Acquisition of Phantom Stock

Mary Ellen Coe, a director at Merck & Co., reported the acquisition of phantom stock units on March 31, 2025.

Summary

• On March 31, 2025, Mary Ellen Coe, a director of Merck & Co., acquired phantom stock units.
• The transaction involved 334.2246 phantom stock units, convertible to common stock on a 1-for-1 basis.
• The price of the derivative security was $89.76.
• Following the transaction, Ms. Coe directly owns 24,567.8829 shares of common stock, including shares acquired through dividend reinvestment transactions.
• The phantom stock units will be settled in cash upon Ms. Coe's termination of service, according to a pre-elected distribution schedule.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing, so the sentiment is neutral.

Future Outlook

The phantom stock units will be settled in cash upon the reporting person's termination of service, according to a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders (directors, officers, and 10% owners) of publicly traded companies, providing transparency into their transactions in the company's securities.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates

Keywords

Form 4, Merck & Co., Director, Mary Ellen Coe, Phantom Stock, Beneficial Ownership, MRK